Omeprazole

Revision as of 19:29, 30 November 2010 by Cassandra Abueg (talk | contribs) (Reverted edits by Aldis506356 (Talk) to last version by Swilliams)
Jump to navigation Jump to search

Synonyms / Brand Names: Omeprazol, Omeprazolum, OMEP, OMZ, OMP, Omeprazole magnesium, Antra, Audazol, Aulcer, Belmazol, Ceprandal, Danlox, Demeprazol, Desec, Dizprazol, Dudencer, Elgam, Emeproton, Epirazole, Erbolin, Exter, Gasec, Gastrimut, Gastroloc, Gibancer, Indurgan, Inhibitron, Inhipump, Lensor, Logastric, Lomac, Losec, Mepral, Miol, Miracid, Mopral, Morecon, Nilsec, Nopramin, Ocid, Olexin, Omapren, Omebeta 20, Omed, Omegast, Omepral, Omeprazon, Omeprol, Omesek, Omezol, Omezolan, Omid, Omisec, Omizac, Ompanyt, Ortanol, Osiren, Ozoken, Paprazol, Parizac, Pepticum, Pepticus, Peptilcer, Prazentol, Prazidec, Prazolit, Prilosec, Procelac, Proclor, Prysma, Ramezol, Regulacid, Result, Sanamidol, Secrepina, Tedec Ulceral, Ulceral, Ulcesep, Ulcometion, Ulcozol, Ulcsep, Ulsen, Ultop, Ulzol, Victrix, Zefxon, Zegerid, Zepral, Zimor, Zoltum

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

For short-term treatment of active duodenal ulcer the recommended adult oral dose of Omeprazole Delayed-Release Capsules is 20 mg once daily. Most patients heal within four weeks. Some patients may require an additional four weeks of therapy.
See Instructions for Administration for additional dosing and administration of Omeprazole Delayed-Release Capsules to treat H. pylori eradication for the reduction of the risk of duodenal ulcer recurrence, gastric ulcer, gastroesophageal reflux disease, maintenance of healing of erosive esophagitis, pathological hypersecretory conditions, pediatric patients, and alternative administration options.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Omeprazole

Return to top

Publication Resources

Most Recent Articles on Omeprazole

Review Articles on Omeprazole

Articles on Omeprazole in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Omeprazole

Return to top

Trial Resources

Ongoing Trials with Omeprazole at Clinical Trials.gov

Trial Results with Omeprazole

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Omeprazole

Cochrane Collaboration on Omeprazole

Cost Effectiveness of Omeprazole

Return to top

Media Resources

Powerpoint Slides on Omeprazole

Images of Omeprazole

Podcasts & MP3s on Omeprazole

Videos on Omeprazole

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Omeprazole

Discussion Groups on Omeprazole

Patient Handouts on Omeprazole

Blogs on Omeprazole

Omeprazole in the News

Omeprazole in the Marketplace

Return to top

International Resources

Omeprazole en Español

Return to top


Adapted from the FDA Package Insert.